StockNews.com initiated coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a research note released on Saturday. The firm issued a sell rating on the biotechnology company’s stock. Other equities analysts have also issued reports about the stock. Morgan Stanley cut their price objective on shares of NanoString Technologies from $14.00 to $8.00 […]